{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:54:11Z","timestamp":1793134451891,"version":"4.5.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>\n            Preeclampsia is characterized by angiogenic imbalance (AI), sFlt-1 (soluble fms-like tyrosine kinase-1)\/PlGF (placental growth factor) is useful for its diagnosis and prediction of adverse outcomes, but the relationship among the degrees of AI as assessed by this ratio with the correct diagnosis, clinical characteristics, and outcomes in women with clinical diagnosis of preeclampsia are unclear. We studied 810 women with clinical diagnosis of preeclampsia. Patients were divided into 3 groups based on their degree of AI, evaluated by the sFlt-1\/PlGF ratio: no AI (\u226438), mild AI (&gt;38\u2013&lt;85), and severe AI (\u226585). Patients with no AI were more likely to have comorbidities and false significant proteinuria compared with patients with mild and severe AI (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001). The rates of preterm delivery, delivery within 14 days, and small-for-gestational-age infant were higher among patients with severe AI than in patients with no and mild AI (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001) and in patients with mild AI that in those with no AI (\n            <jats:italic>P<\/jats:italic>\n            \u22640.01). The occurrence of any adverse maternal outcome (HELLP syndrome, elevated liver enzymes, thrombocytopenia, placental abruption, acute kidney injury) was only present in patients with severe AI. Interestingly, the frequency of misdiagnosis of preeclampsia was progressively lower as the degrees of AI increased (no AI: 100%, mild AI: 88.2%, and severe AI: 15.6%). We concluded that in women with clinical diagnosis of preeclampsia, severe AI is characterized by high frequency of true preeclampsia and preeclampsia-related adverse outcomes, in contrast, no and mild AI, are characterized by unnecessary early deliveries, often due to misdiagnosis.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.120.15552","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T09:00:36Z","timestamp":1595840436000},"page":"892-900","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":57,"title":["Usefulness of the sFlt-1\/PlGF (Soluble fms-Like Tyrosine Kinase-1\/Placental Growth Factor) Ratio in Diagnosis or Misdiagnosis in Women With Clinical Diagnosis of Preeclampsia"],"prefix":"10.1161","volume":"76","author":[{"given":"Alfredo","family":"Lea\u00f1os-Miranda","sequence":"first","affiliation":[{"name":"From the Medical Research Unit in Reproductive Medicine (A.L.-M., A.G.N.-L., R.I.C.-J., C.J.M.-P.), UMAE-Hospital de Ginecolog\u00eda y Obstetricia \u201cLuis Castelazo Ayala\u201d, Instituto Mexicano del Seguro Social (IMSS), Ciudad de M\u00e9xico; Research Unit in Thrombosis, Hemostasia and Atherogenesis, HGR No.1 \u201cDr. Carlos Mac Gregor\u201d, IMSS."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Graciela Nolasco-Lea\u00f1os","sequence":"additional","affiliation":[{"name":"From the Medical Research Unit in Reproductive Medicine (A.L.-M., A.G.N.-L., R.I.C.-J., C.J.M.-P.), UMAE-Hospital de Ginecolog\u00eda y Obstetricia \u201cLuis Castelazo Ayala\u201d, Instituto Mexicano del Seguro Social (IMSS), Ciudad de M\u00e9xico; Research Unit in Thrombosis, Hemostasia and Atherogenesis, HGR No.1 \u201cDr. Carlos Mac Gregor\u201d, IMSS."},{"name":"Posgrado e Investigaci\u00f3n Biomedicina y Biotecnolog\u00eda Molecular, Instituto Polit\u00e9cnico Nacional, Ciudad de M\u00e9xico (A.G.N.-L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyes","family":"Ismael Carrillo-Ju\u00e1rez","sequence":"additional","affiliation":[{"name":"From the Medical Research Unit in Reproductive Medicine (A.L.-M., A.G.N.-L., R.I.C.-J., C.J.M.-P.), UMAE-Hospital de Ginecolog\u00eda y Obstetricia \u201cLuis Castelazo Ayala\u201d, Instituto Mexicano del Seguro Social (IMSS), Ciudad de M\u00e9xico; Research Unit in Thrombosis, Hemostasia and Atherogenesis, HGR No.1 \u201cDr. Carlos Mac Gregor\u201d, IMSS."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Jos\u00e9 Molina-P\u00e9rez","sequence":"additional","affiliation":[{"name":"From the Medical Research Unit in Reproductive Medicine (A.L.-M., A.G.N.-L., R.I.C.-J., C.J.M.-P.), UMAE-Hospital de Ginecolog\u00eda y Obstetricia \u201cLuis Castelazo Ayala\u201d, Instituto Mexicano del Seguro Social (IMSS), Ciudad de M\u00e9xico; Research Unit in Thrombosis, Hemostasia and Atherogenesis, HGR No.1 \u201cDr. Carlos Mac Gregor\u201d, IMSS."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Janet Sillas-Pardo","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine (L.J.S.-P., K.L.R.-V.), UMAE-Hospital de Ginecolog\u00eda y Obstetricia \u201cLuis Castelazo Ayala\u201d, Instituto Mexicano del Seguro Social (IMSS), Ciudad de M\u00e9xico; Research Unit in Thrombosis, Hemostasia and Atherogenesis, HGR No.1 \u201cDr. Carlos Mac Gregor\u201d, IMSS."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Manuel Jim\u00e9nez-Trejo","sequence":"additional","affiliation":[{"name":"Intensive Care Unit (L.M.J.-T.), UMAE-Hospital de Ginecolog\u00eda y Obstetricia \u201cLuis Castelazo Ayala\u201d, Instituto Mexicano del Seguro Social (IMSS), Ciudad de M\u00e9xico; Research Unit in Thrombosis, Hemostasia and Atherogenesis, HGR No.1 \u201cDr. Carlos Mac Gregor\u201d, IMSS."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Isordia-Salas","sequence":"additional","affiliation":[{"name":"Ciudad de M\u00e9xico (I.I.-S)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Leticia Ram\u00edrez-Valenzuela","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine (L.J.S.-P., K.L.R.-V.), UMAE-Hospital de Ginecolog\u00eda y Obstetricia \u201cLuis Castelazo Ayala\u201d, Instituto Mexicano del Seguro Social (IMSS), Ciudad de M\u00e9xico; Research Unit in Thrombosis, Hemostasia and Atherogenesis, HGR No.1 \u201cDr. Carlos Mac Gregor\u201d, IMSS."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1016248"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.107928"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17189"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031884"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055352"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328357c0c9"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.054361"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.00754"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006005"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414838"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13348"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199715100-00001"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198107000-00002"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2180-z"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02293"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641955.2013.784788"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.02.012"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/10641950701521742"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.191213"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000437382.03963.88"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.089334"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2014.01.003"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2009.09.016"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.12760"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.18894"},{"key":"e_1_3_3_27_2","first-page":"561","article-title":"Differences between concentrations of angiogenic factors in preeclampsia and gestational hypertension and their relationship with adverse maternal and perinatal outcome.","volume":"85","author":"Romero-Arauz JF","year":"2017","unstructured":"Romero-Arauz, JF, \u00c1lvarez-Jim\u00e9nez, MG, Encalada-Mijangos, A, P\u00e9rez-Vald\u00e9s, MC, Chan-Verdugo, RG, Lea\u00f1os-Miranda, A. Differences between concentrations of angiogenic factors in preeclampsia and gestational hypertension and their relationship with adverse maternal and perinatal outcome. Ginecol Obstet Mex. 2017;85:561\u2013568.","journal-title":"Ginecol Obstet Mex"},{"key":"e_1_3_3_28_2","volume-title":"Pathology of Toxaemia of Pregnancy","author":"Sheehan HJ","year":"1973","unstructured":"Sheehan, HJ, Lynch, JB. Pathology of Toxaemia of Pregnancy. Baltimore, MD: Williams and Wilkins Co.;1973."},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0412.2011.01111.x"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141571"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-018-0536-9"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4096847"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.120.15552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:45:56Z","timestamp":1715597156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.120.15552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.120.15552"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.120.15552","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"2020-05-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}